Evidence map›Paper›PMID 40727720›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2025

Glo-In-One-v2: holistic identification of glomerular cells, tissues, and lesions in human and mouse histopathology.

Lining Yu, Mengmeng Yin, Ruining Deng, Quan Liu, Tianyuan Yao, Can Cui, Junlin Guo, Yu Wang, Yaohong Wang, Shilin Zhao and 2 more

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. How Close Are We? Limitations and Progress of AI Models in Banff Lesion Scoring.Proceedings of SPIE--the International Society for Optical Engineering · 2026
    Article
  5. Glo-VLMs: Leveraging Vision-Language Models for Fine-Grained Diseased Glomerulus Classification.Proceedings of SPIE--the International Society for Optical Engineering · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lining YuVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Mengmeng YinVanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States.
Ruining DengVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0001-6300-8518
Quan LiuVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Tianyuan YaoVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0002-1848-079X
Can CuiVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Junlin GuoVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Yu WangVanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States.
Yaohong WangUT MD Anderson Cancer Center, Department of Anatomical Pathology, Houston, Texas, United States.
Shilin ZhaoVanderbilt University Medical Center, Department of Biostatistics, Nashville, Tennessee, United States.
Haichun YangVanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0003-4265-7492
Yuankai HuoVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0002-2096-8065

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
KPMP Kidney Mapping and Atlas Project (KMAP)U01DK133090 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$10.4M
Integrated spatial interrogation of cellular and molecular signatures of human kidney diseaseU01DK114923 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Tarek Maurice Ashkar, Pierre C Dagher · 2022 to 2026
$5.4M
Controlling Quality and Capturing Uncertainty in Advanced Diffusion Weighted MRIR01EB017230 · NIBIB · VANDERBILT UNIVERSITY · PI LANDMAN, BENNETT A. · 2015 to 2024
$5.1M
Single cell multiomic and spatial atlas of acute and chronic kidney injuryU01DK114933 · NIDDK · WASHINGTON UNIVERSITY · PI Sanjay Jain · 2022 to 2026
$5.0M
RESOLUTION OF GLOMERULOSCLEROSISR01DK056942 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FOGO, AGNES B. · 2001 to 2021
$4.9M
Spatial Multi-Omics to Profile Metabolic Pathways for Kidney DiseaseU01DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Christopher R Anderton, Kumar Sharma · 2022 to 2026
$3.9M
Boston Chronic Kidney Disease Research Biopsy CenterU01DK133092 · NIDDK · BOSTON MEDICAL CENTER · PI Sylvia E Rosas, Sushrut S. Waikar · 2022 to 2026
$3.5M
Multimodal Imaging Mass Spectrometry and Spatial Omics for the Human KidneyU01DK133766 · NIDDK · VANDERBILT UNIVERSITY · PI Jeffrey M Spraggins · 2022 to 2026
$3.4M
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)U01DK114907 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Nir Hacohen, Jeffrey Benton Hodgin · 2022 to 2026
$3.2M
University of Illinois at Chicago KPMP CKD Recruitment SiteU01DK133081 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAMES P. LASH, Ana Catherine Ricardo · 2022 to 2026
$2.7M
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)U01DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Chirag R Parikh · 2022 to 2026
$2.6M
NIBIB NIH HHS R01 EB017230NIBIB NIH HHS R01 EB033385NIDDK NIH HHS R01 DK056942NIDDK NIH HHS R01 DK132338NIDDK NIH HHS R01 DK135597NIDDK NIH HHS U01 DK114866NIDDK NIH HHS U01 DK114907NIDDK NIH HHS U01 DK114908NIDDK NIH HHS U01 DK114920NIDDK NIH HHS U01 DK114923NIDDK NIH HHS U01 DK114933NIDDK NIH HHS U01 DK133081NIDDK NIH HHS U01 DK133090NIDDK NIH HHS U01 DK133091NIDDK NIH HHS U01 DK133092NIDDK NIH HHS U01 DK133093NIDDK NIH HHS U01 DK133095NIDDK NIH HHS U01 DK133097NIDDK NIH HHS U01 DK133113NIDDK NIH HHS U01 DK133766NIDDK NIH HHS U01 DK133768NIDDK NIH HHS U24 DK114886NIDDK NIH HHS UH3 DK114861NIDDK NIH HHS UH3 DK114915NIDDK NIH HHS UH3 DK114926NIDDK NIH HHS UH3 DK114937NIMH NIH HHS RF1 MH125931
6 · The paper itself

Abstract

Purpose: Segmenting intraglomerular tissue and glomerular lesions traditionally depends on detailed morphological evaluations by expert nephropathologists, a labor-intensive process susceptible to interobserver variability. Our group previously developed the Glo-In-One toolkit for integrated glomerulus detection and segmentation. We leverage the Glo-In-One toolkit to version 2 (Glo-In-One-v2), which adds fine-grained segmentation capabilities. We curated 14 distinct labels spanning tissue regions, cells, and lesions across 23,529 annotated glomeruli from human and mouse histopathology data. To our knowledge, this dataset is among the largest of its kind to date. Approach: We present a single dynamic-head deep learning architecture for segmenting 14 classes within partially labeled images from human and mouse kidney pathology. The model was trained on data derived from 368 annotated kidney whole-slide images with five key intraglomerular tissue types and nine glomerular lesion types. Results: The glomerulus segmentation model achieved a decent performance compared with baselines and achieved a 76.5% average Dice similarity coefficient. In addition, transfer learning from rodent to human for the glomerular lesion segmentation model has enhanced the average segmentation accuracy across different types of lesions by more than 3%, as measured by Dice scores. Conclusions: We introduce a convolutional neural network for multiclass segmentation of intraglomerular tissue and lesions. The Glo-In-One-v2 model and pretrained weight are publicly available at https://github.com/hrlblab/Glo-In-One_v2.

Indexed as

glomerular lesionglomerular segmentationopen-sourcerenal pathologytransfer learningwhole-slide image

Identifiers

PMID40727720
PMCPMC12303538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.